Impact of China on the Pharmaceutical Industry – Thematic Research
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The China pharma market size was US$149.8 billion in 2019 and the market is expected to grow at a CAGR of more than 12% between 2019 and 2029. China has the second largest pharma market in the world behind the US. The government has identified biopharma as a key industry for economic development. Recent regulatory reforms and national strategic initiatives are shifting focus from generics towards R&D innovation.
The impact of China on the pharmaceutical industry research report provides an assessment of the major industry, regulatory, macroeconomic, and technological trends shaping the Chinese pharma industry. The report also provides an overview of key regulatory and market access information, market drivers and barriers, and key players in the Chinese pharma sector.
For more insights on the China pharma market forecast, download a free report sample
Key Trends in the China Pharma Market
The key trends that are impacting the China pharma market can be classified into industry trends, macroeconomic trends, technology trends, and regulatory trends.
- Industry Trends: The key industry trends impacting the China pharma market include the dominance of generics, the expansion of biosimilars, the regenerative medicine sector, and others.
- Macroeconomic Trends – The key macroeconomic trends that will shape the China pharma market are US-China relations and the improvement of the overall health of the people of China.
- Technology Trends: The key technology trends impacting the China pharma market are the increasing use of AI in pharma, 5G, and the emerging 3D industry.
- Regulatory Trends: The key regulatory trend impacting the China pharma market is the reforms to attract overseas companies. China has continually sought to make its market more accessible to international drug manufacturers and attract foreign companies by implementing multiple regulatory changes to allow for faster drug approval timelines and clearer guidelines
China Pharma Industry Analysis
The China pharma market size was US$149.8 billion in 2019, and as the innovation gap between China and other countries narrows, it is well positioned to increase its presence in the global market. The number of total deals per year in this sector has increased between 2011 to 2020, with the highest jump seen in 2020, fuelled by COVID-19.
China Pharma Industry Segmentation by Clinical Trials
The number of clinical trials in China has risen over the past decade. Oncology, central nervous system, infectious disease, genito urinary system and sex hormones, metabolic disorders, and others are the key types of clinical trials. The number of trials in oncology has seen the biggest growth from 2011 to 2020.
China Pharma Industry Analysis by Clinical Trials
For more insights on the clinical trials of China pharma industry, download a free report sample
China Pharma Industry Segmentation by Marketed Products
According to GlobalData’s Companies Database, there are more than 800 companies with drugs currently marketed in China. The key types of marketed drugs are generic, biosimilar, and innovator. Generic has the largest market share.
China Pharma Industry Analysis by Marketed Products
For more insights on the marketed products in the China pharma industry, download a free report sample
China Pharma Market Value Chain
In China, the pharmaceutical supply chain consists of primary and secondary manufacturing, market warehouses/distribution centers, wholesalers, retail shops/hospitals, and patients. Wholesalers, retailers, hospitals, and manufacturers are the major distributors, but patients usually fill prescriptions in a hospital pharmacy for convenience and quality assurance.
Leading Companies in the China Pharma Market
The leading companies in the China pharma market are Jiangsu Hengrui Medicine, Innovent Biologics, CSPC Pharmaceutical Group, Gan & Lee Pharmaceuticals, and others.
Key Themes Impacting the Pharmaceutical Industry
The key themes impacting the China pharma industry are mergers and acquisitions, 5G, augmented and virtual reality (AR & VR), artificial intelligence (AI), biosimilars, and immuno-oncology among others.
For more insights on the themes impacting the China pharma industry, download a free report sample
China Pharma Market Overview
Report Pages | 117 |
Regions Covered | China |
Market Size (2019) | $149.8 billion |
CAGR (2019-2029) | >12% |
Key Trends | Industry Trends, Technology Trends, Macroeconomic Trends, and Regulatory Trends |
Key Clinical Trials | Oncology, Central Nervous System, Infectious Disease, Genito Urinary System and Sex Hormones, Metabolic Disorders, and Others |
Key Marketed Product Type | Generic, Biosimilar, and Innovator |
Value Chains | Primary and Secondary Manufacturing, Market Warehouse/Distribution Centers, Wholesalers, Retail Shops/Hospitals, and Patients |
Leading Companies | Jiangsu Hengrui Medicine, Innovent Biologics, CSPC Pharmaceutical Group, Gan & Lee Pharmaceuticals, and Others |
Scope
This report provides an assessment of the major industry, regulatory, macroeconomic, and technology trends shaping the Chinese pharma industry. It provides detailed analysis of deals, clinical trials, marketed and pipeline products, and contract manufacturing. It also provides an overview of key regulatory and market access information, market drivers and barriers, and key players in the Chinese pharma sector
Reasons to Buy
The report will help you to:
- See what trends are shaping the Chinese pharma market and driving innovation, including key government policies and strategic initiatives.
- See how emerging areas such as immuno-oncology, regenerative medicine, and biosimilars are developing.
- Get an analysis of China’s strong manufacturing and outsourcing sector, including plans to further strengthen these capabilities.
- See how emerging technologies such as 5G, artificial intelligence, and 3D printing are set to drive pharma innovation in China
Table of Contents
Frequently asked questions
-
What was the China pharma market size in 2019?
The China pharma market size was US$149.8 billion in 2019.
-
What is the China pharma market growth rate?
The China pharma market is expected to grow at a CAGR of more than 12% between 2019 and 2029.
-
What key industry trends are impacting the China pharma market?
The key industry trends impacting the China pharma market include the dominance of generics, the expansion of biosimilars, the regenerative medicine sector, and others.
-
What key macroeconomic trends are shaping the China pharma market?
The key macroeconomic trends that will shape the China pharma market are US-China relations, and the improvement of the overall health of the people of China.
-
What key technology trends are shaping the China pharma market?
The key technology trends are the increasing use of AI in pharma, 5G, and the emerging 3D industry.
-
What key regulatory trend is shaping the China pharma market?
The key regulatory trend is the reforms to attract overseas companies.
-
What are the key types of clinical trials in the China pharma market?
Oncology, central nervous system, infectious disease, genito urinary system and sex hormones, and metabolic disorders among others are the key types of clinical trials.
-
What key types of marketed products in the China pharma market?
The key types of marketed products in the China pharma market are generic, biosimilar, and innovator.
-
What are the components of the China pharma industry value chains?
The China pharma industry value chain can be split into primary and secondary manufacturing, market warehouse/distribution centers, wholesalers, retail shops/hospitals, and patients.
-
Which are the leading companies in the China pharma industry?
The leading companies in the China pharma industry are Jiangsu Hengrui Medicine, Innovent Biologics, CSPC Pharmaceutical Group, Gan & Lee Pharmaceuticals, and others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.